{
    "clinical_study": {
        "@rank": "16781", 
        "arm_group": [
            {
                "arm_group_label": "Starting with FLORENCED2  followed by open loop", 
                "arm_group_type": "Experimental", 
                "description": "Start 2 Overnight periods  with closed loop through  FLORENCED2 Device , followed by 2 overnight periods with open loop."
            }, 
            {
                "arm_group_label": "Start open loop followed by FLORENCED2", 
                "arm_group_type": "Experimental", 
                "description": "Start  with 2 overnight periods with open loop , followed by 2 overnight with closed loop FLORENCED2"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to validate  current algorithms and evaluate  safety and\n      efficacy of overnight  closed loop insulin delivery (FlorenceD2 system) in children with\n      type 1 diabetes between 6 - 12 years of age in Luxembourg ."
        }, 
        "brief_title": "Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between 6 - \u226412 years\n\n          -  With type 1 diabetes for 6 months  or more and\n\n          -  Pump user for at least 6 months.\n\n          -  HbAc1 should be <11 %.\n\n          -  No medication or physical or psychological disease should be present, which could\n             interfere with the study.\n\n        Exclusion Criteria:\n\n        -None"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02099409", 
            "org_study_id": "SPIDLUX 4"
        }, 
        "intervention": {
            "arm_group_label": [
                "Starting with FLORENCED2  followed by open loop", 
                "Start open loop followed by FLORENCED2"
            ], 
            "description": "FLORENCED2 device ensures the closed loop between Freestyle Navigator II and the DANA DIABECARE R", 
            "intervention_name": "FLORENCED2", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Type 1 diabetes mellitus", 
            "children", 
            "closed loop", 
            "cross over", 
            "overnight", 
            "FLORENCED2", 
            "DANA Diabecare R pump", 
            "FreeStyle Navigator II", 
            "Dexcom G4"
        ], 
        "lastchanged_date": "March 27, 2014", 
        "link": {
            "description": "SPIDLUX 4 is a sub study of the SPIDIMAN project", 
            "url": "http://www.spidiman.eu"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Luxembourg", 
                        "country": "Luxembourg", 
                        "zip": "1210"
                    }, 
                    "name": "DECCP Clinique P\u00e9diatrique de Luxembourg/CHL"
                }, 
                "investigator": [
                    {
                        "last_name": "Carine de Beaufort, MD PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ulrike Schierloh, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "schierloh.ulrike@chl.lu", 
                    "last_name": "Ulrike Schierloh, MD", 
                    "phone": "+35244113173"
                }, 
                "contact_backup": {
                    "email": "debeaufort.carine@chl.lu", 
                    "last_name": "Carine de Beaufort, MD, PhD", 
                    "phone": "+35244113173"
                }, 
                "facility": {
                    "address": {
                        "city": "Luxembourg", 
                        "country": "Luxembourg", 
                        "zip": "1210"
                    }, 
                    "name": "DECCP Pediatric Clinic , CHLuxembourg"
                }, 
                "investigator": [
                    {
                        "last_name": "Carine de Beaufort, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ulrike Schierloh, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Luxembourg"
        }, 
        "number_of_arms": "2", 
        "official_title": "Open Label Single Center Randomized Cross Over Study to Validate Current Algorithms and Evaluate Safety and Efficacy of Closed Loop Insulin Delivery (FlorenceD2 System) in Children With Type 1 Diabetes Between 6 - 12 Years of Age", 
        "overall_contact": {
            "email": "schierloh.ulrike@chl.lu", 
            "last_name": "Ulrike Schierloh, MD", 
            "phone": "+35244113173"
        }, 
        "overall_contact_backup": {
            "email": "debeaufort.carine@chl.lu", 
            "last_name": "Carine de Beaufort, MD, PhD", 
            "phone": "+35244113173"
        }, 
        "overall_official": [
            {
                "affiliation": "Centre Hospitalier du Luxembourg", 
                "last_name": "Carine deBeaufort, MD PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Cambridge", 
                "last_name": "Roman Hovorka, Professor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Cambridge", 
                "last_name": "Gosia Wilinska, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Centre Hospitalier du Luxembourg", 
                "last_name": "Ulrike Schierloh, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Luxembourg: Comite National d'Ethique de Recherche", 
                "Luxembourg: Minist\u00e8re de la Sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Glucose will be measured with a  Continuous glucose monitoring device", 
            "measure": "Time spent in normal glucose range ( mg/dl)", 
            "safety_issue": "Yes", 
            "time_frame": "At least 5 hours between 7 pm and 7 am"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02099409"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier du Luxembourg", 
            "investigator_full_name": "Carine de Beaufort", 
            "investigator_title": "MD , PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Continuous Glucose Monitoring device", 
                "measure": "glucose variability ( excursions in mg/dl)", 
                "safety_issue": "Yes", 
                "time_frame": "7 pm - 7 am"
            }, 
            {
                "description": "Continuous Glucose Monitoring", 
                "measure": "Time spent in low glucose range (< 60 mg/dl)", 
                "safety_issue": "Yes", 
                "time_frame": "7 pm till 7 am"
            }, 
            {
                "description": "continuous glucose monitoring", 
                "measure": "time spent in low glucose range (<70 mg/dl)", 
                "safety_issue": "Yes", 
                "time_frame": "7 pm till 7 am"
            }, 
            {
                "description": "continuous glucose monitoring", 
                "measure": "time spent in high glucose range (>180mg/dl)", 
                "safety_issue": "Yes", 
                "time_frame": "7 pm - 7 am"
            }
        ], 
        "source": "Centre Hospitalier du Luxembourg", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Cambridge", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Centre Hospitalier du Luxembourg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}